| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/29/2010 | WO2010048552A2 Methods of using oligomeric compounds comprising 2'-substituted nucleosides |
| 04/29/2010 | WO2010048549A2 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom |
| 04/29/2010 | WO2010048536A2 Processes for preparing lipids |
| 04/29/2010 | WO2010048446A2 Modulation of axon degeneration |
| 04/29/2010 | WO2010048444A1 Use of t-loop in trans-splicing polynucleotides |
| 04/29/2010 | WO2010047839A1 Modified plant virus particles and uses therefor |
| 04/29/2010 | WO2010047829A1 Mutant hepatitis c virus e2 polypeptides for hcv treatment |
| 04/29/2010 | WO2010047310A1 Tumor antigen peptide and use thereof |
| 04/29/2010 | WO2010047216A1 METHOD FOR INHIBITING FUNCTION OF micro-RNA |
| 04/29/2010 | WO2010045570A1 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs |
| 04/29/2010 | WO2010027279A3 Compositions and methods for the treatment and prevention of neoplastic disorders |
| 04/29/2010 | WO2010008576A3 Idna vaccines and methods for using the same |
| 04/29/2010 | WO2009143483A3 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 04/29/2010 | US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 04/29/2010 | US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100104662 Composition and methods for modulating cell proliferation and cell death |
| 04/29/2010 | US20100104577 Methods and materials related to anti-a (beta) antibodies |
| 04/29/2010 | US20100104537 Methods of treating Parkinson's disease using viral vectors |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | CA2741294A1 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom |
| 04/29/2010 | CA2741089A1 Modulation of axon degeneration |
| 04/29/2010 | CA2674454A1 Improved hcv vaccines and methods for using the same |
| 04/28/2010 | EP2180057A1 Vector system |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP1427828B1 Random integration of a polynucleotide after in vivo linearization |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | EP1346036B1 Helper virus-free herpes virus amplicon particles and uses thereof |
| 04/28/2010 | EP1297107B1 Intervertebral disc |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | CN1880458B Human source chromosome targeting vector of human beta-globin gene cluster and application therefor |
| 04/28/2010 | CN1860228B Staple type oligonucleotide and drug comprising the same |
| 04/28/2010 | CN1820020B SARS-coronavirus virus-like particles and methods of use |
| 04/28/2010 | CN1813066B Novel beta-actin and rps21 promoters and uses thereof |
| 04/28/2010 | CN1668359B Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs |
| 04/28/2010 | CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/28/2010 | CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 04/28/2010 | CN101698852A Protein or polypeptide with function of CD137L, and gene and application thereof |
| 04/28/2010 | CN101698848A Goldfish autonomous transposon gene gfTol2, transposase coded by gene, and use of gene |
| 04/28/2010 | CN101142614B Single channel image resampling system and method using anisotropic filtering |
| 04/27/2010 | US7705196 sFRP expression enhancing agent |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705139 Zinc finger proteins for DNA binding and gene regulation in plants |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705016 administering small molecule capable of inhibiting CPT1(carnitine palmitoyl transferase1) is 2-tetradecylglydate (TDGA) or (R)-N-(tetradecylcarbamoyl)-aminocarnitine |
| 04/27/2010 | US7704970 DNA vaccination for treatment of autoimmune disease |
| 04/27/2010 | US7704969 Transfection complexes |
| 04/27/2010 | US7704968 treating cancer with antisense oligonucleotide complementary to a region of a nuclear factor- kappa B(NF- kappa B) subunit mRNA, contains phosphate backbone chemically modified; leukemia, fibroblast cancer; inhibiting septic shock; biocompatibility with no side effect |
| 04/27/2010 | US7704967 TFIIS and GDOWN1 as targets for cancer therapy |
| 04/27/2010 | US7704965 Methods and materials for treating human papillomavirus infections |
| 04/27/2010 | US7704964 Methods and compounds for the targeting of protein to exosomes |
| 04/27/2010 | US7704962 Small oligonucleotides with anti-tumor activity |
| 04/27/2010 | US7704954 Method and carrier complexes for delivering molecules to cells |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704688 Using RNA interference to prevent and treat viral diseases |
| 04/27/2010 | US7704686 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof |
| 04/27/2010 | US7704685 In vivo production of a clostridial neurotoxin light chain peptide |
| 04/27/2010 | US7704512 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 04/27/2010 | US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 04/27/2010 | US7704493 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 04/27/2010 | US7704492 providing recombinant adeno-associated virus (AAV) virion which comprises an AAV vector, AAV vector comprising selected gene operably linked to control elements capable of directing in vivo transcription and translation of selected gene and introducing recombinant AAV virion into muscle cell or tissue |
| 04/27/2010 | US7704272 Method for introducing an ultraviolet light activated viral vector into the spinal column |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/22/2010 | WO2010045598A2 Psma binding ligand-linker conjugates and methods for using |
| 04/22/2010 | WO2010045573A2 Tumor vaccine |
| 04/22/2010 | WO2010045512A2 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 04/22/2010 | WO2010045369A2 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells |
| 04/22/2010 | WO2010044464A1 Modified amyloid beta peptide |
| 04/22/2010 | WO2010043630A2 A delivery system for rna |
| 04/22/2010 | WO2010043243A1 Novel diagnostic and therapeutic agents |
| 04/22/2010 | WO2009158040A3 Cancer platinum resistance detection and sensitization method |
| 04/22/2010 | WO2009155535A3 Compositions, methods and kits for eliciting an immune response |
| 04/22/2010 | US20100099748 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 04/22/2010 | US20100099742 Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines |
| 04/22/2010 | US20100099740 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/22/2010 | US20100099105 Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (bcrp) |
| 04/22/2010 | US20100098760 Polypeptide for treating or preventing adhesions |
| 04/22/2010 | US20100098697 Chlamydia trachomatis antigens |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/22/2010 | US20100098666 Humanized Viral Vectors and Methods of Use Thereof |
| 04/22/2010 | US20100098663 Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA |
| 04/22/2010 | US20100098638 RIP140 Regulation of Diabetes |
| 04/22/2010 | US20100098625 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/22/2010 | US20100098624 Method for using cdo antagonists to modulate hedgehog signaling |
| 04/22/2010 | CA2743828A1 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells |
| 04/22/2010 | CA2740779A1 Tumor vaccine |
| 04/22/2010 | CA2739046A1 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177619A1 HSV strains for the oncolytic treatment of cancer |
| 04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
| 04/21/2010 | EP2177228A1 DNA vaccination for treatment of autoimmune disease |
| 04/21/2010 | EP2176283A2 Methods and compositions for treating brain diseases |
| 04/21/2010 | EP2176277A2 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
| 04/21/2010 | EP1667732B1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/21/2010 | EP1141361B1 Compositions and methods for packaging of alphavirus vectors |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |